These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 18605642)

  • 1. [Overactive bladder. When it's pressing, immediate help is indicated].
    Widhalm S
    MMW Fortschr Med; 2008 May; 150(20):44-5. PubMed ID: 18605642
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary urgency].
    MMW Fortschr Med; 2008 Jul; 150(28-31):58-9. PubMed ID: 19009709
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment with solifenacin reduces urinary urgency and improves quality of life. Results of the non-interventional CAP-study].
    Kalchthaler M; Mühlich S; Rothe P
    MMW Fortschr Med; 2011 Jan; 152 Suppl 4():119-24. PubMed ID: 21598462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of overactive urinary bladder with imperative urinary incontinence in women].
    Neĭmark AI; Riapolova MV; Mel'nik MA
    Urologiia; 2010; (2):36-8. PubMed ID: 20967993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder.
    Tanaka Y; Masumori N; Tsukamoto T
    Int J Urol; 2010 Sep; 17(9):796-800. PubMed ID: 20649825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solifenacin.
    Kreder KJ
    Urol Clin North Am; 2006 Nov; 33(4):483-90, ix. PubMed ID: 17011384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solifenacin succinate for the treatment of symptoms of overactive bladder.
    Maniscalco M; Singh-Franco D; Wolowich WR; Torres-Colón R
    Clin Ther; 2006 Sep; 28(9):1247-72. PubMed ID: 17062299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with a better therapeutic effect of solifenacin in patients with overactive bladder syndrome.
    Hsiao SM; Lin HH; Kuo HC
    Neurourol Urodyn; 2014 Mar; 33(3):331-4. PubMed ID: 23494586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
    Schaefer W
    BJU Int; 2009 Feb; 103(4):554-5. PubMed ID: 19187349
    [No Abstract]   [Full Text] [Related]  

  • 10. [Overactive bladder. New anticholinergic drug controls urinary urge].
    MMW Fortschr Med; 2004 Jul; 146(27-28):51. PubMed ID: 15526670
    [No Abstract]   [Full Text] [Related]  

  • 11. [A placebo-controlled, double-blind, randomized trial of single daily dose of anti-muscarinic drug solifenacin succinate in patients with overactive bladder].
    Cardozo L; Lisec M; Milard R; Van Vierssen Trip O; Kuzmin I; Drogendijk TE; Huang AM
    Akush Ginekol (Sofiia); 2007; 46(5):55-7. PubMed ID: 17974184
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and tolerability of solifenacin in patients aged ≥ 65 years with overactive bladder: post-hoc analysis of 2 open-label studies.
    Capo' JP; Lucente V; Forero-Schwanhaeuser S; He W
    Postgrad Med; 2011 Jan; 123(1):94-104. PubMed ID: 21293089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: A pooled analysis.
    Drinka PJ
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):292-3; author reply 293. PubMed ID: 17062331
    [No Abstract]   [Full Text] [Related]  

  • 14. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Solifenacin in treatment of the overactive bladder syndrome--diagnosis, clinical management and results].
    Slavov Ch; Popov E; Slavov S; Dimitrov R; Doganov N; Chernev T
    Akush Ginekol (Sofiia); 2010; 49(3):16-21. PubMed ID: 20734651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary.
    Yokoyama O; Yamaguchi O; Kakizaki H; Itoh N; Yokota T; Okada H; Ishizuka O; Ozono S; Gotoh M; Sugiyama T; Seki N; Yoshida M; Yamada S
    J Urol; 2011 Jul; 186(1):170-4. PubMed ID: 21575976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solifenacin may improve sleep quality in patients with overactive bladder and sleep disturbance.
    Takao T; Tsujimura A; Yamamoto K; Fukuhara S; Nakayama J; Matsuoka Y; Miyagawa Y; Nonomura N
    Urology; 2011 Sep; 78(3):648-52. PubMed ID: 21676440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity.
    Ronchi P; Gravina GL; Galatioto GP; Costa AM; Martella O; Vicentini C
    Neurourol Urodyn; 2009; 28(1):52-7. PubMed ID: 18671288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of solifenacin for overactive bladder symptoms, symptom bother, and health-related quality of life in patients by duration of self-reported symptoms: a secondary analysis of the VIBRANT study.
    Gollar KM; Young DG; Bailen J; He W; Forero-Schwanhaeuser S
    Urol Nurs; 2012; 32(1):38-46, 50. PubMed ID: 22474864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing treatments for overactive bladder.
    Waine E; Stott M
    Nurs Times; 2008 Oct 14-20; 104(41):45-8. PubMed ID: 18979960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.